Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Robert J. Sealock 2 Articles
Endoscopic vacuum therapy for treatment of spontaneous and iatrogenic upper gastrointestinal defects
Kavea Panneerselvam, Jake S. Jacob, Ronald E. Samuel, Andy Tau, Gyanprakash A. Ketwaroo, Wasif M. Abidi, Robert J. Sealock
Clin Endosc 2023;56(6):754-760.   Published online May 9, 2023
DOI: https://doi.org/10.5946/ce.2022.177
Graphical AbstractGraphical Abstract AbstractAbstract PDFPubReaderePub
Background
/Aims: Endoscopic vacuum therapy (EVT) can heal a variety of defects within the gastrointestinal (GI) tract via applying negative pressure, which reduces the defect size, aspirates the infected fluid, and promotes granulation tissue. Here we present our experience with EVT as it relates to both spontaneous and iatrogenic upper GI tract perforations, leaks, and fistulas.
Methods
This retrospective study was conducted at four large hospital centers. All patients who underwent EVT between June 2018 and March 2021 were included. Data on multiple variables were collected, including demographics, defect size and location, number and intervals of EVT exchanges, technical success, and hospital length of stay. Student t-test and the chi-squared test were used to analyze the data.
Results
Twenty patients underwent EVT. The most common defect cause was spontaneous esophageal perforation (50%). The most common defect location was the distal esophagus (55%). The success rate was 80%. Seven patients were treated with EVT as the primary closure method. The mean number of exchanges was five with a mean interval of 4.3 days between exchanges. The mean length of hospital stay was 55.8 days.
Conclusions
EVT is a safe and effective initial management option for esophageal leaks and perforations.

Citations

Citations to this article as recorded by  
  • Endoscopic vacuum therapy: management of upper gastrointestinal anastomotic leaks and esophageal perforations
    María de Armas Conde, Carmen Díaz-López , Vanessa Concepción-Martín, María Del Pilar Borque-Barrera
    Revista Española de Enfermedades Digestivas.2024;[Epub]     CrossRef
  • Management of fistulas in the upper gastrointestinal tract
    Maria Valeria Matteo, Maria Mihaela Birligea, Vincenzo Bove, Valerio Pontecorvi, Martina De Siena, Loredana Gualtieri, Federico Barbaro, Cristiano Spada, Ivo Boškoski
    Best Practice & Research Clinical Gastroenterology.2024; 70: 101929.     CrossRef
  • Endoscopic Vacuum Therapy of Upper Gastrointestinal Anastomotic Leaks: How to Deal with the Challenges (with Video)
    Laurent Monino, Tom G. Moreels
    Life.2023; 13(6): 1412.     CrossRef
  • 2,470 View
  • 146 Download
  • 2 Web of Science
  • 3 Crossref
Close layer
Evaluating the Revised American Society for Gastrointestinal Endoscopy Guidelines for Common Bile Duct Stone Diagnosis
Jake S. Jacob, Michelle E. Lee, Erin Y. Chew, Aaron P. Thrift, Robert J. Sealock
Clin Endosc 2021;54(2):269-274.   Published online November 6, 2020
DOI: https://doi.org/10.5946/ce.2020.100
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background
/Aims: The American Society for Gastrointestinal Endoscopy (ASGE) revised its guidelines for risk stratification of patients with suspected choledocholithiasis. This study aimed to assess the diagnostic performance of the revision and to compare it to the previous guidelines.
Methods
We conducted a retrospective cohort study of 267 patients with suspected choledocholithiasis. We identified high-risk patients according to the original and revised guidelines and examined the diagnostic accuracy of both guidelines. We measured the association between individual criteria and choledocholithiasis.
Results
Under the original guidelines, 165 (62%) patients met the criteria for high risk, of whom 79% had confirmed choledocholithiasis. The categorization had a sensitivity and specificity of 68% and 55%, respectively, for the detection of choledocholithiasis. Under the revised guidelines, 86 (32%) patients met the criteria for high risk, of whom 83% had choledocholithiasis. The revised categorization had a lower sensitivity and higher specificity of 37% and 80%, respectively. The positive predictive value of the high-risk categorization increased with the revision, reflecting a potential decrease in diagnostic endoscopic retrograde cholangiopancreatograpies (ERCPs). Stone visualized on imaging had the greatest specificity for choledocholithiasis. Gallstone pancreatitis was not associated with the risk for choledocholithiasis.
Conclusions
The 2019 revision of the ASGE guidelines decreases the utilization of ERCP as a diagnostic modality and offers an improved risk stratification tool.

Citations

Citations to this article as recorded by  
  • Endoscopic ultrasound avoids diagnostic ERCP among the ASGE high-risk group – Experience in an Asian population
    Weng-Fai Wong, Yu-Ting Kuo, Ming-Lun Han, Hsiu-Po Wang
    Journal of the Formosan Medical Association.2024; 123(3): 374.     CrossRef
  • Rendimiento diagnóstico de la endosonografía biliopancreática en pacientes con riesgo intermedio de coledocolitiasis
    Lázaro Antonio Arango Molano, Andrés Sánchez Gil, Claudia Patricia Diaz Tovar, Andrés Valencia Uribe, Christian Germán Ospina Pérez, Pedro Eduardo Cuervo Pico, Rodrigo Alberto Jiménez Gómez
    Revista de Gastroenterología del Perú.2024; 44(1): 8.     CrossRef
  • Suspected common bile duct stones: reduction of unnecessary ERCP by pre-procedural imaging and timing of ERCP
    Christina J. Sperna Weiland, Evelien C. Verschoor, Alexander C. Poen, Xavier J. M. N. Smeets, Niels G. Venneman, Abha Bhalla, Ben J. M. Witteman, Hester C. Timmerhuis, Devica S. Umans, Jeanin E. van Hooft, Marco J. Bruno, P. Fockens, Robert C. Verdonk, Jo
    Surgical Endoscopy.2023; 37(2): 1194.     CrossRef
  • Low Detection Rates of Bile Duct Stones During Endoscopic Treatment for Highly Suspected Bile Duct Stones with No Imaging Evidence of Stones
    Hirokazu Saito, Hajime Iwasaki, Hisashi Itoshima, Yoshihiro Kadono, Takashi Shono, Kentaro Kamikawa, Atsushi Urata, Jiro Nasu, Masayoshi Uehara, Ikuo Matsushita, Tatsuyuki Kakuma, Shuji Tada
    Digestive Diseases and Sciences.2023; 68(5): 2061.     CrossRef
  • Effect of Frailty on the Management of Suspected Choledocholithiasis
    Katherine C. Bergus, Rondi B. Gelbard, Sara Scarlet, Shruthi Srinivas, Brett M. Tracy
    The American Surgeon™.2023; 89(7): 3104.     CrossRef
  • Prospective assessment of the accuracy of ASGE and ESGE guidelines for choledocholithiasis
    Andy Silva-Santisteban, Ishani Shah, Madhuri Chandnani, Vaibhav Wadhwa, Leo Tsai, Abraham F. Bezuidenhout, Tyler M. Berzin, Douglas Pleskow, Mandeep Sawhney
    Endoscopy International Open.2023; 11(06): E599.     CrossRef
  • ERCP findings provide further justification for a “surgery-first” mindset in choledocholithiasis
    Gloria Sanin, Gabriel Cambronero, James Patterson, Maggie Bosley, Aravindh Ganapathy, Carl Wescott, Lucas Neff
    Surgical Endoscopy.2023; 37(11): 8714.     CrossRef
  • Dynamic changes in liver function tests do not correctly reclassify patients at risk of choledocholithiasis beyond ASGE 2019 criteria
    Tatiana Ramírez-Peña, Rómulo Darío Vargas-Rubio, Carlos Ernesto Lombo, Luis Miguel Rodríguez-Hortua, Oscar Mauricio Muñoz-Velandia
    Therapeutic Advances in Gastrointestinal Endoscopy.2023;[Epub]     CrossRef
  • National adherence to the ASGE-SAGES guidelines for managing suspected choledocholithiasis: An EAST multicenter study
    Brett M. Tracy, Benjamin K. Poulose, Cameron W. Paterson, April E. Mendoza, Apostolos Gaitanidis, Jonathan M. Saxe, Andrew J. Young, Martin D. Zielinski, Carrie A. Sims, Rondi B. Gelbard
    Journal of Trauma and Acute Care Surgery.2022; 92(2): 305.     CrossRef
  • Accuracy of SAGES, ASGE, and ESGE criteria in predicting choledocholithiasis
    Kinzang Wangchuk, Pongsakorn Srichan
    Surgical Endoscopy.2022; 36(10): 7233.     CrossRef
  • Evaluation of the American Society of Gastrointestinal Endoscopy 2019 and the European Society of Gastrointestinal Endoscopy guidelines' performances for choledocholithiasis prediction in clinically suspected patients: A retrospective cohort study
    Suppadech Tunruttanakul, Borirak Chareonsil, Kotchakorn Verasmith, Jayanton Patumanond, Chatchai Mingmalairak
    JGH Open.2022; 6(6): 434.     CrossRef
  • Test Performance Characteristics of Dynamic Liver Enzyme Trends in the Prediction of Choledocholithiasis
    Yang Lei, B. Lethebe, Erin Wishart, Fateh Bazerbachi, B. Elmunzer, Nirav Thosani, James Buxbaum, Yen-I Chen, Sydney Bass, Martin Cole, Christian Turbide, Darren Brenner, Steven Heitman, Rachid Mohamed, Nauzer Forbes
    Journal of Clinical Medicine.2022; 11(15): 4575.     CrossRef
  • Criterios ASGE 2010 frente a 2019 para coledocolitiasis en pacientes llevados a colangiopancreatografía retrógrada endoscópica
    Ana María Lourido Gamboa, Guillermo Vallejo Vallecilla, Jesús Eduardo Díaz Realpe, Katheryn Daniela Lagos Castro, Juan David Guzmán Sandoval, Angela María Merchán Galvis
    Revista colombiana de Gastroenterología.2022; 37(4): 362.     CrossRef
  • Optimal Predictive Criteria for Common Bile Duct Stones: The Search Continues
    Yun Nah Lee, Jong Ho Moon
    Clinical Endoscopy.2021; 54(2): 147.     CrossRef
  • 5,830 View
  • 298 Download
  • 14 Web of Science
  • 14 Crossref
Close layer

Clin Endosc : Clinical Endoscopy Twitter Facebook
Close layer
TOP